ZTS as of Oct 31 · 16:52 ET
ZTSNYSEPharmaceutical Preparations

Zoetis Inc. · Brief

Next report

3 days

Nov 3 · before openest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±6.9%
avg realized
±7.4%
Nov 4 '24±6.3%▼−3.72%×0.59
Feb 13 '25±5.6%▼−5.15%×0.92
May 6 '25±6.4%▼−5.18%×0.81
Aug 5 '25±6.1%▼−3.75%×0.61
Q3 FY25±6.2%▼−13.78%×2.22
Feb 12 '26±6.7%▼−2.35%×0.35
Q1 FY26±7.7%▼−21.50%×2.79
Q2 FY26±10.4%▲+3.87%×0.37
quarterimplied−25%0+25%realized×
Q2 FY26±10.4%▲+3.87%×0.37
Q1 FY26±7.7%▼−21.50%×2.79
Feb '26±6.7%▼−2.35%×0.35
Q3 FY25±6.2%▼−13.78%×2.22
Aug '25±6.1%▼−3.75%×0.61
May '25±6.4%▼−5.18%×0.81
2 older reports
Feb '25±5.6%▼−5.15%×0.92
Nov '24±6.3%▼−3.72%×0.59
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2

1,442managers reporting a position in the latest quarterly filings13F · Jun 30 '26
11tracked funds holding ZTSN-PORT · Aug 31 '26

Bear2 of 4

16.00%revenue from the largest disclosed customer U.S. veterinary distributorSEC filings
79managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ZTS report session
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±8.9% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.